Home Nav
Nextech Invest Logo
Nextech Invest

Nextech Invest focuses on investing in companies that are entering clinical development with a clear path to exit within three years. This strategy enables Nextech Invest to minimize investment risks while maintaining an optimal level of return for our investors. Nextech Invest's management team retains board positions in portfolio companies to contribute to the value growth.

The portfolio of Nextech Invest is not limited by geographical company location, specific oncology indications, or market size. We favor validated, first-in-class scientific concepts that have the potential to give a meaningful impact for cancer patients.

What are clinical trials?

Clinical trials are designed to test the safety and efficacy of a new drug. After a drug has been through preclinical testing in laboratory experiments and animal models, it undergoes three rigorous phases of human clinical trials: safety, efficacy and superiority. The trial data are used for balancing effective dosing and side effects.

Close

Newsletter Registration

Please fill in the subscription form completely. If you wish to modify your personal data or to change/cancel your newsletter subscription, this is possible at any time.

A link to your subscription profile can be found in every newsletter email.

Preview

* Compulsory fields

Close

Newsletter Registration

Your eMail have been successfully registered.

Close